Maximize Every Revenue Moment

PLATON

Photographer and Founder

The People’s Portfolio

Rainmaker19 is proud to announce its opening guest keynote speaker, Platon, World-Renowned, Award-Winning Photographer and Founder, The People’s Portfolio. Platon has captured the portraits of some of the most famous, powerful and influential people of our time from Vladimir Putin to Bill Clinton, Steven Spielberg to Serena Williams, Bill Gates to Bono. Find out how this award-winning photographer and author, Peabody Award winner and human rights activist finds the truth and authenticity in his well-known subjects.

Andy Molnar

Sr. Director, Market Access at Cognoa

Andy brings 11 years of pharmaceutical industry experience, specifically bridging technology with business needs. Andy has focused on optimizing operational systems and building consistencies in business processes to build powerful analytics platforms. He transitioned his more technically focused background into market access strategy and contract operations. Combining the technical with pharma, Andy recently decided to join the expanding industry of using digital interventions to diagnose and treat disease. Andy has been instrumental in defining market access launch strategies for multiple digital therapeutics companies and building the infrastructure to manage this new modality.

Dave Cannell

Managing Director at Cumberland Consulting Group

Emily Yang

VP, WW Sales and Marketing, Diodes

Ms. Yang was appointed Vice President of Worldwide Sales and Marketing in mid-December 2017. She has been with Diodes since the acquisition of Pericom Semiconductor Corporation in November 2015, where she was Vice President of Global Sales. Prior to that, she held a number of sales management positions with Pericom including: Contract Manufacturing Sales Director, Western Regional Sales Director, and Strategic Account Sales Director covering Asia, North America, and Europe. Ms. Yang holds a BA in Economics from the University of Toronto.

John Lewis

Sr. Director, Product Strategy and Development at BPI

With more than 18 years at BPI, John is responsible for product strategy and development of the GTN solution where he oversees product delivery for all implementations. He has major influence in strategic planning and R&D activities focused on extending BPI’s product offering to address industry needs and requirements. John also manages BPI’s advisory board with clients and industry resources to develop leading technology solutions and defining the product roadmap for the Model N BPI GTN solution.

John Schiavone

Solutions Principal at Model N

John Schiavone is a Solution Engineer with 12 years of experience with Model N and over 20 years of experience in the Life Science industry providing technology solutions to business objectives. John has implemented Revenue Management projects for several of the top Pharmaceutical and Med Tech companies and he brings in depth knowledge of contracting, pricing, quoting, rebates, chargebacks, compliance, master data management as well as reporting and analytics. John is currently on the sales team to help customers with their challenges, find solutions to their problems and educate them on the value of Model N Revenue Execution, especially to the Med Tech community.

Krishna Shekhram

Model N

Larry Walsh

CEO and Principal Analyst, The 2112 Group

Larry Walsh is one of the most recognizable figures in the IT channel and is considered one of the more forward-thinking leaders in the industry. As the founder of The 2112 Group – a business strategy firm focused on improving the performance of technology companies – he works with clients ranging from Fortune 100 service providers to innovative start-ups on growth strategies, enablement, and channel program development to drive repeatable revenue.

An award-winning journalist, Walsh is also founder of Channelnomics.com, a blog about the business models and best practices of indirect technology channels.

Nancy Doherty

Director of Pricing, Contracts and Reimbursement at Ferring Pharmaceuticals

Nick Merryfield

CEO of Verpora

Nick Merryfield is a CEO with over twenty years of international experience in the life sciences industry. He is a visionary leader who thrives on pioneering new methods to deliver positive outcomes in a continually evolving healthcare environment. Nick’s approach has led to a highly successful career in which he has created innovative organizations across market access, RWE, HEOR, publishing, training and clinical trial management. More recently, Nick has dedicated his time to working in the field of outcomes-based, innovative contracting in the U.S. and across global markets.

Central to Nick’s philosophy is his focus on seeing the challenge from every stakeholder’s perspective. At Verpora this is witnessed in his desire to ensure the organization delivers value to payers, manufacturers, health systems and the patients they serve. Nick takes an active operational role in the company, heading the Business Consulting division.

Omar Ali

Head of Payers at Verpora

Qualified with a hospital pharmacy background, Omar has been working a Pharmacy Payer for over 15 years, and has been an adviser to NICE Government HTA body for 10 years. He heads up the Payer team at Verpora, with a collaborative network of 150 US & EU current and former payers with expertise in value based agreements. Omar has embarked on a PhD with his doctorate thesis entitled “Value Based Pricing & Outcomes Based, Innovative Contracting of New Medicines”, his most recent publication on the use of innovative reimbursement models for curative CAR-T cell and gene therapies.

Patrick Tobin

Assoc. Director, Professional Services at Model N

Patrick has spent the past 11 years with Model N as integral member of Model N driving customer success in implementations. For over 5 years he was Regulatory Lead before extending his knowledge to the Commercial applications. In recent years, Patrick has been the Functional Lead on major projects, overseeing delivery of the end-to-end solution. Patrick continues to expand his responsibilities, most recently having taken on the role of COE Lead for RTS (RMaaS Testing Service).

Rangaraman Rajagopalan

Director, Information Systems at EMD Serono

Robert Blank

Alliance Life Sciences

Managing Consultant at EVERSANA

Robert Blank is a managing consultant at Eversana, working extensively in revenue management software solutions for the pharmaceutical and medical device industries. His expertise includes Medicaid and Managed Care rebates, chargebacks, and membership management. He has developed custom client solutions around value based contracting, formulary validation, discount reallocation, and the 340B Drug Pricing Program. In his speaking engagements and published articles, Robert focuses on outlining industry trends and the impacts of legislation upon commercial operations.

Tracy Bordas

Stryker

Manager, Strategic Contracts & Pricing at Stryker

Tracy Bordas started at Stryker Orthopaedics in Mahwah, NJ 5 years ago. She joined the company as a Contracts & Pricing analyst and transitioned to Manager of Strategic Contracts & Pricing. Tracy is currently responsible for the contracts and pricing analytics for the West sales area, Government sales support, and the Sales Operations Rotational Program. She received her Bachelor’s Degree in Finance and Management from Rider University and recently received her MBA from Ramapo College of New Jersey.

Cesare Rotundo

Model N

Senior Director, Product Management, Model N

Cesare is the Product Management leader for Model N’s High Tech product portfolio, including Revenue Cloud (Channel Management, Deal Management), Channel Data Management, and Salesforce-native solutions including Sales for Semiconductors and Rebate Management. Before Model N he led Product Management for BPM-based industry solutions at Oracle, Supply Chain collaboration solutions at E2open, and Price and Margin Management at Vendavo. He delivered large implementation projects as a Senior Manager at Deloitte, and was a Software Engineer at IBM. Cesare holds an MBA from INSEAD, #1 in the Financial Times Global MBA Ranking for the second year running, and an MS in Computer Science.

Neelabh Saxena

HighPoint Solutions

Sr. Principal, Pricing and Contracting Strategy and Analytics at HighPoint Solutions

Neelabh Saxena is a Senior Principal within the Pricing, Contracting & Market Access practice at HighPoint Solutions, with more than 10 years of Life Sciences industry experience focusing on Global Market Access, Commercial Strategy, Gross to Net Forecasting, Medicaid and Government Pricing. Prior to HighPoint, Neelabh was a consultant at ZS Associates and Michael Allen Company (a boutique healthcare strategy consulting company) focusing on pharmaceutical marketing strategy and analytics. His academic credentials include a Masters Diploma in Global Market Access from EMAUD, France; Masters in Pharmaceutical Economics from Barcelona School of Management; an MBA from New York University, a M.S. in MIS from Texas A &M University and a B.E in Computer Engineering from University of Delhi.i.

John Shakow

King & Spalding

Partner at King & Spalding

John Shakow is a Partner, King & Spalding. John’s practice focuses on complex regulatory, commercial and litigation issues related to all aspects of drug pricing and price reporting. He counsels pharmaceutical and biotechnology clients on their rights and obligations under the Medicaid, Medicare, Federal Supply Schedule, 340B and TRICARE programs. He has extensive experience helping clients resolve commercial, strategic, organizational and other legal challenges while maintaining the integrity of their price reporting compliance efforts.

Ruven Remo Eul

HighPoint Solutions

Sr. Principal, Global Pricing and Tender Management at HighPoint Solutions

Ruven is a Sr. Principal within the European Pricing, Contracting and Market Access team based out of Zug, Switzerland responsible for project oversight and delivery, resource management as well as business and solution development. Ruven brings a background of industry experiences in large pharma from companies such as Pfizer and BMS where he worked in Commercial roles with a large focus on leading cross functional Tendering teams for Pfizer in Germany. While at HighPoint Solutions, Ruven has worked with emerging, mid-tier and large pharma on various Tendering and Contracting programs from policy and process assessments, outsourcing of business functions, software vendor evaluations and implementation of global programs. Additionally, Ruven has conducted the industry’s first Benchmarking Study on Tendering issuing 4 reports presenting the benchmarking results and developed HighPoint’s Tender Data Service, THOR, focusing on supporting the awareness & planning phase of Tendering while building Competitive and Pricing Intelligence. In parallel, Ruven has also worked deeply in global commercial effectiveness programs.

Tom Evegan

Cumberland Consulting Group

Tom Evegan, Managing Director at Cumberland Consulting Group

As Managing Director of Cumberland’s Contracts, Pricing and Compliance Practice, Evegan identifies strategic opportunities, generates new business and develops partnerships that accelerate the growth of the firm’s consulting and managed services to the pharmaceutical industry. Prior to joining Cumberland, Evegan was vice president of government and commercial consulting for CIS and has held leadership roles in the areas of finance, managed markets, as well as contracts and pricing, for organizations on both the Payer and Pharma/Biotech sides of the industry. He is a frequent speaker and panelist at prominent industry conferences, covering topics such as drug commercialization, government pricing and market access strategies.